Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (67)	9/6/1997 7:43:00 PM
From: John McCarthy	of 569

FYI:From Barron's 9/8/97 In their Research Reports section (page 61), Ladenburg Thalman says the following: ... The potential annual market for this treatment in the US is estimated to be about six million patients who suffer from pain and stiffness in the knees that imparis their mobility. We expect Synvisc will become the second billion-dollar drug to have been deveolped by the company's founder. The enormous commercial potential open to Synvisc has prompted a number of major drug companies to enter into alliances with Biomatrix .... End of their statement. I had no idea the Gross Market $ had this potential. Does anyone know? (1) What was the first billion dollar drug developed by Biomatrix's founder? (2) How to get a listing of mutual funds that own this puppy? Thanks. John McCarthy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next